Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.

Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA; RIS-HEP13 and GEHEP 011 study groups.

AIDS. 2019 Jun 1;33(7):1167-1174. doi: 10.1097/QAD.0000000000002186.

PMID:
30845068
2.

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Podzamczer D, Rozas N, Domingo P, Miralles C, den Eynde EV, Romero A, Deig E, Knobel H, Pasquau J, Antela A, Clotet B, Geijo P, de Castro ER, Casado MA, Muñoz A, Casado A, For The Pro-Str Study Group.

Curr HIV Res. 2018;16(6):425-435. doi: 10.2174/1570162X17666190212163518.

PMID:
30760189
3.

Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.

Berenguer J, Jarrín I, Pérez-Latorre L, Hontañón V, Vivancos MJ, Navarro J, Téllez MJ, Guardiola JM, Iribarren JA, Rivero-Juárez A, Márquez M, Artero A, Morano L, Santos I, Moreno J, Fariñas MC, Galindo MJ, Hernando MA, Montero M, Cifuentes C, Domingo P, Sanz J, Domíngez L, Ferrero OL, De la Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, Losa JE, Vilaró J, Bernal E, Arponen S, Ortí AJ, Chocarro Á, Teira R, Alonso G, Silvariño R, Vegas A, Geijo P, Bisbe J, Esteban H, González-García J; GeSIDA 8514 Study Group.

Open Forum Infect Dis. 2018 Jan 12;5(1):ofx258. doi: 10.1093/ofid/ofx258. eCollection 2018 Jan.

4.

Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.

Teira R, Vidal F, Muñoz-Sánchez P, Geijo P, Viciana P, Ribera E, Domingo P, Castaño M, Martínez E, Roca B, Puig T, Estrada V, Deig E, Galindo MJ, de la Fuente B, Lozano F, Montero M, Muñoz-Sanz A, Sanchez T, Terrón A, Romero-Palacios A, Lacalle JR, Garrido M, Suárez-Lozano I; VACH Study Group.

HIV Med. 2017 Mar;18(3):196-203. doi: 10.1111/hiv.12413. Epub 2016 Aug 1.

5.

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.

Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, Vergara A, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Muñoz J, Fernandez P, Geijo P, de Castro ER, Diz J, Casado A, Torres C.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19814. doi: 10.7448/IAS.17.4.19814. eCollection 2014.

6.

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort.

Estrada V, Geijo P, Fuentes-Ferrer M, Alcalde ML, Rodrigo M, Galindo MJ, Muñoz A, Domingo P, Ribera E, Cosín J, Viciana P, Lozano F, Terrón A, Vergara A, Teira R, Muñoz-Sánchez J, Roca B, Sánchez T, López-Aldeguer J, Deig E, Vidal F, Pedrol E, Castaño-Carracedo M, Puig T, Garrido M, Suárez-Lozano I.

BMC Womens Health. 2011 Aug 4;11:36. doi: 10.1186/1472-6874-11-36.

7.

C-reactive protein for discriminating treatment failure from slow responding pneumonia.

Ruiz-González A, Falguera M, Porcel JM, Martínez-Alonso M, Cabezas P, Geijo P, Boixeda R, Dueñas C, Armengou A, Capdevila JA, Serrano R.

Eur J Intern Med. 2010 Dec;21(6):548-52. doi: 10.1016/j.ejim.2010.09.006.

PMID:
21111942
8.

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Diaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

BMC Infect Dis. 2010 Sep 14;10:267. doi: 10.1186/1471-2334-10-267.

9.

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.

Teira R, Suárez-Lozano I, Lozano F, Viciana P, Domingo P, Galindo P, Geijo P, Terrón A, González J, Cosín J, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sánchez A, Vergara A, López-Aldeguer J, Pedrol E, Vidal F, Garrido M, Santamaría JM.

Enferm Infecc Microbiol Clin. 2010 May;28(5):266-72. doi: 10.1016/j.eimc.2009.04.018. Epub 2010 Feb 2.

PMID:
20129716
10.

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patients.

Suarez-Lozano I, Viciana P, Lacalle JR, Teira R, Lozano F, Lopez-Aldeguer J, Pedrol E, Domingo P, Cosin J, Roca B, Geijo P, Fuente B, Vergara A, Ribera E, Galindo MJ, Zapata A, Sanchez T, Vidal F, Munoz-Sanz A, Munoz-Sanchez J, Garrido M.

HIV Med. 2009 Oct;10(9):573-9. doi: 10.1111/j.1468-1293.2009.00731.x.

11.

[Factors related to non-prescription of tuberculin skin testing in a cohort of HIV-infected people].

Díaz A, Diez M, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaría JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Enferm Infecc Microbiol Clin. 2010 Apr;28(4):215-21. doi: 10.1016/j.eimc.2009.06.008. Epub 2009 Aug 15. Spanish.

PMID:
19683364
12.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

Crespo M, Ribera E, Suárez-Lozano I, Domingo P, Pedrol E, López-Aldeguer J, Muñoz A, Viladés C, Sánchez T, Viciana P, Teira R, García-Alcalde ML, Vergara A, Lozano F, Galindo MJ, Cosin J, Roca B, Terrón A, Geijo P, Vidal F, Garrido M; VACH Cohort Study Group.

J Antimicrob Chemother. 2009 Jan;63(1):189-96. doi: 10.1093/jac/dkn450. Epub 2008 Nov 6.

PMID:
18988678
13.

Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic.

Gómez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Muñoz A, López C.

Clin Vaccine Immunol. 2008 Jun;15(6):1031-3. doi: 10.1128/CVI.00424-07. Epub 2008 Apr 30.

14.

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.

Domingo P, Suárez-Lozano I, Torres F, Teira R, Lopez-Aldeguer J, Vidal F, Muñoz A, Viciana P, Lozano F, Vergara A, Roca B, García Alcalde ML, Cosín J, Terrón A, Galindo MJ, Geijo P, Ribera E, Gonzalez J, Sanchez T, Lacalle JR, Garrido M.

J Antimicrob Chemother. 2008 Jun;61(6):1348-58. doi: 10.1093/jac/dkn121. Epub 2008 Mar 20.

PMID:
18356150
15.

Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain.

Diez M, Diaz A, Bleda MJ, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P, Iribarren JA, Moreno S, Moreno ME, Labarga P, Pinilla J, Portu J, Pulido F, Rosa C, Santamaria JM, Telenti M, Trapiella L, Trastoy M, Viciana P.

Int J Tuberc Lung Dis. 2007 Nov;11(11):1196-202.

PMID:
17958981
16.

[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].

Teira R, Suárez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, Terrón A, Vergara A, Geijo P, Arribas JR, Cosín J, Domingo P, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sanz A.

Enferm Infecc Microbiol Clin. 2005 Apr;23(4):213-7. Spanish.

PMID:
15826546
17.

A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.

Solera J, Geijo P, Largo J, Rodriguez-Zapata M, Gijón J, Martinez-Alfaro E, Navarro E, Macia MA; Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Clin Infect Dis. 2004 Dec 15;39(12):1776-82. Epub 2004 Nov 19.

PMID:
15578399
18.

Hepatitis C virus and human immunodeficiency virus coinfection in Spain.

Roca B, Suarez I, Gonzalez J, Garrido M, de la Fuente B, Teira R, Geijo P, Cosin J, Perez-Cortes S, Galindo MJ, Lozano F, Domingo P, Viciana P, Ribera E, Vergara A, Sánchez T.

J Infect. 2003 Aug;47(2):117-24.

PMID:
12860144
19.

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

Suárez-Lozano I, Fajardo JM, Garrido M, Roca B, García-Alcalde ML, Geijo P, Selma D, Lozano F, Teira R, Viciana P, Pérez-Cortés S, Domingo P, Menchero A, Galindo MJ, Cosín J, Ribera E, Arribas JR, Lacalle JR.

AIDS. 2002 Dec 6;16(18):2496-9. No abstract available.

PMID:
12461432
20.

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group].

Martínez Alfaro EM, Cuadra F, Solera J, Maciá MA, Geijo P, Sánchez Martínez PA, Rodríguez Zapata M, Largo J, Sepúlveda MA, Rosa C, Sánchez L, Espinosa A, Mateos F, Blanch JJ.

Med Clin (Barc). 2000 Jul 1;115(5):161-5. Spanish.

PMID:
10996870
21.

[Comparative study of the Brucellacapt test versus the Coombs test for Brucella].

Gómez MC, Rosa C, Geijo P, Escribano MA.

Enferm Infecc Microbiol Clin. 1999 Jun-Jul;17(6):283-5. Spanish.

PMID:
10439538
22.

Multivariate model for predicting relapse in human brucellosis.

Solera J, Martínez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodríguez-Zapata M.

J Infect. 1998 Jan;36(1):85-92.

PMID:
9515675
23.

[Pulmonary infection by Mycobacterium malmoense in a patient with AIDS].

López R, Redondo MP, Ruiz D, Geijo P.

Enferm Infecc Microbiol Clin. 1997 Jan;15(1):47-8. Spanish. No abstract available.

PMID:
9147514
24.

Treatment of human brucellosis with doxycycline and gentamicin.

Solera J, Espinosa A, Martínez-Alfaro E, Sánchez L, Geijo P, Navarro E, Escribano J, Fernández JA.

Antimicrob Agents Chemother. 1997 Jan;41(1):80-4.

25.

Treatment of human brucellosis with netilmicin and doxycycline.

Solera J, Espinosa A, Geijo P, Martínez-Alfaro E, Sáez L, Sepúlveda MA, Ruiz-Ribó MD.

Clin Infect Dis. 1996 Mar;22(3):441-5.

PMID:
8852960
26.

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Solera J, Rodríguez-Zapata M, Geijo P, Largo J, Paulino J, Sáez L, Martínez-Alfaro E, Sánchez L, Sepulveda MA, Ruiz-Ribó MD.

Antimicrob Agents Chemother. 1995 Sep;39(9):2061-7.

27.

[Disseminated herpes zoster with pneumonitis in an HIV-positive patient].

Geijo P, Santiago M, Ruiz D, de Benito L.

Enferm Infecc Microbiol Clin. 1995 Feb;13(2):128-9. Spanish. No abstract available.

PMID:
7711126
28.

[Brucellar sacroiliitis. A detailed review with an analysis of treatment efficacy].

Solera J, Paulino J, Rodríguez-Zapata M, Medrano F, Geijo P, Jiménez F, de Juan L.

Rev Clin Esp. 1992 Jun;191(1):13-8. Review. Spanish.

PMID:
1631354
29.

[A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].

Solera J, Medrano F, Rodríguez M, Geijo P, Paulino J.

Med Clin (Barc). 1991 May 4;96(17):649-53. Spanish.

PMID:
1905372
30.

Plasmacellular Castleman's disease and POEMS syndrome.

Munoz G, Geijo P, Moldenhauer F, Perez-Moro E, Razquin J, Piris MA.

Histopathology. 1990 Aug;17(2):172-4. No abstract available.

PMID:
2227842
31.

[Surgical treatment of unique cerebral metastasis: survival factors].

Fandiño J, Geijo PM, Botana C, Gómez-Bueno J.

Rev Clin Esp. 1990 Apr;186(7):316-9. Spanish.

PMID:
2392593

Supplemental Content

Support Center